393 related articles for article (PubMed ID: 22776900)
1. Disruption of fatty acid amide hydrolase activity prevents the effects of chronic stress on anxiety and amygdalar microstructure.
Hill MN; Kumar SA; Filipski SB; Iverson M; Stuhr KL; Keith JM; Cravatt BF; Hillard CJ; Chattarji S; McEwen BS
Mol Psychiatry; 2013 Oct; 18(10):1125-35. PubMed ID: 22776900
[TBL] [Abstract][Full Text] [Related]
2. Upregulation of Anandamide Hydrolysis in the Basolateral Complex of Amygdala Reduces Fear Memory Expression and Indices of Stress and Anxiety.
Morena M; Aukema RJ; Leitl KD; Rashid AJ; Vecchiarelli HA; Josselyn SA; Hill MN
J Neurosci; 2019 Feb; 39(7):1275-1292. PubMed ID: 30573646
[TBL] [Abstract][Full Text] [Related]
3. Constitutive Increases in Amygdalar Corticotropin-Releasing Factor and Fatty Acid Amide Hydrolase Drive an Anxious Phenotype.
Natividad LA; Buczynski MW; Herman MA; Kirson D; Oleata CS; Irimia C; Polis I; Ciccocioppo R; Roberto M; Parsons LH
Biol Psychiatry; 2017 Oct; 82(7):500-510. PubMed ID: 28209423
[TBL] [Abstract][Full Text] [Related]
4. Stress-induced modulation of endocannabinoid signaling leads to delayed strengthening of synaptic connectivity in the amygdala.
Yasmin F; Colangeli R; Morena M; Filipski S; van der Stelt M; Pittman QJ; Hillard CJ; Teskey GC; McEwen BS; Hill MN; Chattarji S
Proc Natl Acad Sci U S A; 2020 Jan; 117(1):650-655. PubMed ID: 31843894
[TBL] [Abstract][Full Text] [Related]
5. Sustained glucocorticoid exposure recruits cortico-limbic CRH signaling to modulate endocannabinoid function.
Gray JM; Wilson CD; Lee TT; Pittman QJ; Deussing JM; Hillard CJ; McEwen BS; Schulkin J; Karatsoreos IN; Patel S; Hill MN
Psychoneuroendocrinology; 2016 Apr; 66():151-8. PubMed ID: 26821211
[TBL] [Abstract][Full Text] [Related]
6. Suppression of amygdalar endocannabinoid signaling by stress contributes to activation of the hypothalamic-pituitary-adrenal axis.
Hill MN; McLaughlin RJ; Morrish AC; Viau V; Floresco SB; Hillard CJ; Gorzalka BB
Neuropsychopharmacology; 2009 Dec; 34(13):2733-45. PubMed ID: 19710634
[TBL] [Abstract][Full Text] [Related]
7. Amygdala FAAH and anandamide: mediating protection and recovery from stress.
Gunduz-Cinar O; Hill MN; McEwen BS; Holmes A
Trends Pharmacol Sci; 2013 Nov; 34(11):637-44. PubMed ID: 24325918
[TBL] [Abstract][Full Text] [Related]
8. Reduced anxiety-like behaviour induced by genetic and pharmacological inhibition of the endocannabinoid-degrading enzyme fatty acid amide hydrolase (FAAH) is mediated by CB1 receptors.
Moreira FA; Kaiser N; Monory K; Lutz B
Neuropharmacology; 2008 Jan; 54(1):141-50. PubMed ID: 17709120
[TBL] [Abstract][Full Text] [Related]
9. Corticotropin-releasing hormone drives anandamide hydrolysis in the amygdala to promote anxiety.
Gray JM; Vecchiarelli HA; Morena M; Lee TT; Hermanson DJ; Kim AB; McLaughlin RJ; Hassan KI; Kühne C; Wotjak CT; Deussing JM; Patel S; Hill MN
J Neurosci; 2015 Mar; 35(9):3879-92. PubMed ID: 25740517
[TBL] [Abstract][Full Text] [Related]
10. Alterations in corticolimbic dendritic morphology and emotional behavior in cannabinoid CB1 receptor-deficient mice parallel the effects of chronic stress.
Hill MN; Hillard CJ; McEwen BS
Cereb Cortex; 2011 Sep; 21(9):2056-64. PubMed ID: 21263035
[TBL] [Abstract][Full Text] [Related]
11. Effects of acute and repeated restraint stress on endocannabinoid content in the amygdala, ventral striatum, and medial prefrontal cortex in mice.
Rademacher DJ; Meier SE; Shi L; Ho WS; Jarrahian A; Hillard CJ
Neuropharmacology; 2008 Jan; 54(1):108-16. PubMed ID: 17675104
[TBL] [Abstract][Full Text] [Related]
12. Synergistic interactions between cannabinoids and environmental stress in the activation of the central amygdala.
Patel S; Cravatt BF; Hillard CJ
Neuropsychopharmacology; 2005 Mar; 30(3):497-507. PubMed ID: 15280883
[TBL] [Abstract][Full Text] [Related]
13. Deficient adolescent social behavior following early-life inflammation is ameliorated by augmentation of anandamide signaling.
Doenni VM; Gray JM; Song CM; Patel S; Hill MN; Pittman QJ
Brain Behav Immun; 2016 Nov; 58():237-247. PubMed ID: 27453335
[TBL] [Abstract][Full Text] [Related]
14. Disruption of peri-adolescent endocannabinoid signaling modulates adult neuroendocrine and behavioral responses to stress in male rats.
Lee TT; Hill MN; Hillard CJ; Gorzalka BB
Neuropharmacology; 2015 Dec; 99():89-97. PubMed ID: 26192544
[TBL] [Abstract][Full Text] [Related]
15. Role of the endocannabinoid system in the dorsal hippocampus in the cardiovascular changes and delayed anxiety-like effect induced by acute restraint stress in rats.
Hartmann A; Fassini A; Scopinho A; Correa FM; Guimarães FS; Lisboa SF; Resstel LB
J Psychopharmacol; 2019 May; 33(5):606-614. PubMed ID: 30789299
[TBL] [Abstract][Full Text] [Related]
16. Therapeutic endocannabinoid augmentation for mood and anxiety disorders: comparative profiling of FAAH, MAGL and dual inhibitors.
Bedse G; Bluett RJ; Patrick TA; Romness NK; Gaulden AD; Kingsley PJ; Plath N; Marnett LJ; Patel S
Transl Psychiatry; 2018 Apr; 8(1):92. PubMed ID: 29695817
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of fatty acid amide hydrolase in the central amygdala alleviates co-morbid expression of innate anxiety and excessive alcohol intake.
Stopponi S; Fotio Y; Domi A; Borruto AM; Natividad L; Roberto M; Ciccocioppo R; Cannella N
Addict Biol; 2018 Nov; 23(6):1223-1232. PubMed ID: 29071769
[TBL] [Abstract][Full Text] [Related]
18. Role of the basolateral nucleus of the amygdala in endocannabinoid-mediated stress-induced analgesia.
Connell K; Bolton N; Olsen D; Piomelli D; Hohmann AG
Neurosci Lett; 2006 Apr; 397(3):180-4. PubMed ID: 16378681
[TBL] [Abstract][Full Text] [Related]
19. Chronic treatment with URB597 ameliorates post-stress symptoms in a rat model of PTSD.
Fidelman S; Mizrachi Zer-Aviv T; Lange R; Hillard CJ; Akirav I
Eur Neuropsychopharmacol; 2018 May; 28(5):630-642. PubMed ID: 29519609
[TBL] [Abstract][Full Text] [Related]
20. Anandamide Signaling Augmentation Rescues Amygdala Synaptic Function and Comorbid Emotional Alterations in a Model of Epilepsy.
Colangeli R; Morena M; Pittman QJ; Hill MN; Teskey GC
J Neurosci; 2020 Jul; 40(31):6068-6081. PubMed ID: 32601243
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
